Intriguingly, PVR/PVRL2, which are upregulated and unfavorable prognostic factors in HCC, interact with TIGIT and act as a prominent coinhibitory signal in the TME and was determined in vitro. The gene discussed is PVR; the disease is hepatocellular carcinoma.